{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:17:15Z","timestamp":1788891435418,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clindermatol.2024.12.017","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:54:13Z","timestamp":1734382453000},"page":"177-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"William","family":"Damsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2024.12.017_bib0001","series-title":"Illustrations of Clinical Surgery","first-page":"42","article-title":"Anomalous diseases of skin and fingers: case of livid papillary psoriasis","author":"Hutchinson","year":"1877"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0002","first-page":"1321","article-title":"Multiple benign sarkoid of the skin","volume":"14","author":"Boeck","year":"1899","journal-title":"Norse Mag Laegevid"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0003","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/bmj.2.4058.777","article-title":"The sarcoidosis of Boeck","volume":"2","author":"Scott","year":"1938","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0004","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0005","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0006","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0007","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0009","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0010","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2023.08.004","article-title":"Cutaneous sarcoidosis","volume":"45","author":"Abdelghaffar","year":"2024","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0738-081X(86)90032-5","article-title":"Cutaneous sarcoidosis: definitions and types of lesions","volume":"4","author":"Elgart","year":"1986","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0012","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1684\/ejd.2015.2666","article-title":"Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues","volume":"25","author":"Esteves","year":"2015","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0013","first-page":"86","article-title":"Sarcoidosis on tattoos: a review of the literature from 1939 to 2011","volume":"30","author":"Kluger","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000284584","article-title":"Dermoscopy of cutaneous sarcoidosis","volume":"221","author":"Pellicano","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0015","first-page":"33","article-title":"Lupus pernio de la face [Lupus pernio of the face]","volume":"10","author":"Bessnier","year":"1889","journal-title":"Ann Dermatol Syphiligr"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0016","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0190-9622(90)70061-L","article-title":"Sarcoidosis of the upper respiratory tract in patients with nasal rim lesions: a pilot study","volume":"22","author":"Jorizzo","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0017","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0018","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/DAD.0000000000001509","article-title":"Histopathological features of subcutaneous sarcoidosis","volume":"42","author":"Marcoval","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0019","first-page":"144","article-title":"Un cas de tumeurs benignes multiples: sarcoidosis sous-cutanees ou tubercuildes nodulaires hypoedermiques [A case of multiple benign tumors: subcutaneous sarcoidosis or hypodermic nodular tuberculosis]","volume":"5","author":"Darier","year":"1904","journal-title":"Ann Dermatol Syphiligr"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clindermatol.2019.01.005","article-title":"Sarcoidosis: a great imitator","volume":"37","author":"Karada\u011f","year":"2019","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0021","doi-asserted-by":"crossref","first-page":"154","DOI":"10.12968\/hmed.2015.76.3.154","article-title":"Acute sarcoidosis: Lofgren's syndrome","volume":"76","author":"Kirresh","year":"2015","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0022","first-page":"390","article-title":"The Heerfordt-Waldenstrom syndrome as an initial presentation of sarcoidosis","volume":"26","author":"Denny","year":"2013","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11882-021-00991-3","article-title":"Distinguishing Blau syndrome from systemic sarcoidosis","volume":"21","author":"Kaufman","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0024","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jaad.2018.07.051","article-title":"Immune checkpoint inhibitors and the development of granulomatous reactions","volume":"81","author":"Cornejo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0025","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jaad.2020.12.010","article-title":"Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis","volume":"86","author":"Murphy","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0026","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.semarthrit.2012.03.008","article-title":"Sarcoidosis triggered by interferon-beta treatment of multiple sclerosis: a case report and focused literature review","volume":"42","author":"Chakravarty","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0027","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.rmed.2006.03.004","article-title":"Sarcoidosis after treatment with interferon-\u03b1: a case series and review of the literature","volume":"100","author":"Goldberg","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0028","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1067\/mjd.2000.104679","article-title":"Sarcoidosis of the scalp: a case series and review of the literature","volume":"42","author":"Katta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ad.2022.03.013","article-title":"Dactylitis due to subcutaneous sarcoidosis as a manifestation of sarcoidosis","volume":"114","author":"Marcoval","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0030","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.42.6.634","article-title":"Sarcoid dactylitis","volume":"42","author":"Pitt","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0031","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1468-3083.2012.04473.x","article-title":"Cutaneous sarcoidosis in southern Taiwan: clinicopathologic study of a series with high proportions of lesions confined to the face and angiolupoid variant","volume":"27","author":"Wu","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0032","first-page":"1439","article-title":"Association of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program","volume":"315","author":"Murphy","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0033","first-page":"55","article-title":"Psoriasiform sarcoidosis: collision of two entities or expression of one common pathogenesis?","volume":"9","author":"Vega","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2133.1963.tb13548.x","article-title":"Sarcoidosis with erythrodermia and ulceration","volume":"75","author":"Simpson","year":"1963","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/DAD.0000000000001488","article-title":"Sarcoidosis with cutaneous manifestations of necrobiosis lipoidica","volume":"42","author":"Chandan","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0036","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0095-4543(21)00273-6","article-title":"Cutaneous lesions of sarcoidosis","volume":"5","author":"Elgart","year":"1978","journal-title":"Prim Care"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0037","first-page":"217","article-title":"Digital clubbing in sarcoidosis","volume":"34","author":"Shah","year":"1992","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0038","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1468-3083.2009.03153.x","article-title":"Cutaneous sarcoidosis: a histopathological study","volume":"23","author":"Cardoso","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0039","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0560.2006.00563.x","article-title":"Clinical spectrum and histological analysis of 32 cases of specific cutaneous sarcoidosis","volume":"33","author":"Mangas","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0303-6987.2004.00157.x","article-title":"The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases","volume":"31","author":"Ball","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0041","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jdin.2022.03.004","article-title":"Reactive granulomatous dermatitis: a useful and encompassing term","volume":"7","author":"Wanat","year":"2022","journal-title":"JAAD Int"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0042","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00000372-199906000-00004","article-title":"Epidermal changes in cutaneous lesions of sarcoidosis","volume":"21","author":"Okamoto","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0043","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00000372-200010000-00004","article-title":"Foreign bodies in sarcoidosis","volume":"22","author":"Kim","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0044","first-page":"427","article-title":"Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis","volume":"137","author":"Marcoval","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0045","first-page":"471","article-title":"Cutaneous sarcoidosis and foreign bodies. An electron probe roentgenographic microanalytic study","volume":"119","author":"Val-Bernal","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0046","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ajcp\/90.5.545","article-title":"Calcium oxalate in sarcoid granulomas. With particular reference to the small ovoid body and a note on the finding of dolomite","volume":"90","author":"Reid","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0047","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0560.2007.00854.x","article-title":"Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis","volume":"35","author":"de Jager","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0048","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamadermatol.2022.0828","article-title":"Association of persistent rubella virus with idiopathic skin granulomas in clinically immunocompetent adults","volume":"158","author":"Wanat","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0049","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0051","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0052","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0053","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0272-5231(05)70415-9","article-title":"Immunology of sarcoidosis","volume":"18","author":"Kataria","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0054","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1183\/09031936.00035213","article-title":"Major histocompatibility complex class II and BTNL2 associations in sarcoidosis","volume":"42","author":"Wennerstr\u00f6m","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0055","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF03402194","article-title":"Accumulation of common clonal T cells in multiple lesions of sarcoidosis","volume":"6","author":"Sawabe","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577860","article-title":"The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells","volume":"367","author":"Paley","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0057","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01450-2019","article-title":"Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis","volume":"55","author":"Darlington","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0058","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/595006","article-title":"HIV\/AIDS: immune reconstitution inflammatory syndrome: a reappraisal","volume":"48","author":"French","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0059","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0060","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1007\/s11033-014-3318-z","article-title":"Associations between tumor necrosis factor alpha gene polymorphism and sarcoidosis: a meta-analysis","volume":"41","author":"Xie","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0061","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.chest.2020.12.027","article-title":"Phase II investigation of the efficacy of antimycobacterial therapy in chronic pulmonary sarcoidosis","volume":"159","author":"Drake","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0062","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1183\/09031936.00002607","article-title":"Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis","volume":"30","author":"Gupta","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0063","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between sarcoidosis and infectious agents?: a systematic review and meta-analysis","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0064","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/resp.13482","article-title":"Bidirectional association between tuberculosis and sarcoidosis","volume":"24","author":"Wang","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0065","first-page":"262","article-title":"Role of Propionibacterium acnes in sarcoidosis: a meta-analysis","volume":"30","author":"Zhou","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0066","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210785","article-title":"CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope","volume":"218","author":"Greaves","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0067","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.chest.2017.11.045","article-title":"Sarcoidosis in World Trade Center-exposed firefighters","volume":"153","author":"Reich","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0068","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/thx.42.5.321","article-title":"The K veim response: still useful, still a puzzle","volume":"42","author":"Munro","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0069","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2011.06.017","article-title":"Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway","volume":"66","author":"Judson","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0070","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2796.2003.01230.x","article-title":"Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis","volume":"254","author":"Katchar","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0071","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0072","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09273941003797934","article-title":"The expression of STAT-1 and phosphorylated STAT-1 in conjunctival granulomas","volume":"18","author":"Rosenbaum","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0073","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","article-title":"Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0074","doi-asserted-by":"crossref","first-page":"e44818","DOI":"10.1371\/journal.pone.0044818","article-title":"Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0076","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0077","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0078","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCRESAHA.121.320449","article-title":"Transcriptional and immune landscape of cardiac sarcoidosis","volume":"131","author":"Liu","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0079","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03794-2020","article-title":"Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases","volume":"57","author":"Liao","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0080","article-title":"Immune mapping of human tuberculosis and sarcoidosis lung granulomas","volume":"14","author":"Carow","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0081","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.3390\/cells12232747","article-title":"Spatial transcriptomics reveals signatures of histopathological changes in muscular sarcoidosis","volume":"12","author":"Lequain","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0082","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2024.07.021","article-title":"Spatial transcriptomics reveals organized and distinct immune activation in cutaneous granulomatous disorders","volume":"154","author":"Daccache","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0083","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2023.01.014","article-title":"Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation","volume":"56","author":"Krausgruber","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0084","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178711","article-title":"Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases","volume":"134","author":"Sati","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0085","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0086","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0087","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archderm.1991.01680060108015","article-title":"Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature","volume":"127","author":"Zic","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0088","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.017_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100220","article-title":"Molecularly targeted therapies for inflammatory cutaneous granulomatous disorders: a review of the evidence and implications for understanding disease pathogenesis","volume":"3","author":"Hwang","year":"2023","journal-title":"JID Innov"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T14:33:18Z","timestamp":1744986798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X24002827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0738081X24002827"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.017","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}